Immucor Announces Fiscal Second Quarter Revenue of $81.5M

Immucor BLUD today reported financial results for its fiscal 2011 second quarter ended November 30, 2010. Highlights Revenue for the second quarter of fiscal 2011 was $81.5 million, down approximately $1.0 million or 1% from the prior year quarter. Current quarter revenue was negatively impacted by approximately $1.0 million from fluctuations in foreign currency exchange rates. Gross margin was 71.6% in the quarter compared with 70.4% in the prior year quarter. Diluted earnings per share totaled $0.30 in the quarter compared with $0.28 for the same period last year. Cash flow from operations for the six months ended November 30, 2010 was $47.7 million compared with $34.1 million in the prior year. Worldwide instrument orders for the second quarter of fiscal year 2011 were 29 Echo® orders and 26 NEO® orders. NEO is the Company's new high volume instrument that was recently launched worldwide.